Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.
van Egmond S, van Vliet ED, Wakkee M, Hollestein LM, Pouwels XGLV, Koffijberg H, Misirli Y, Bakkum RSLA, Bastiaens MT, Kukutsch NA, Oosting AJ, Plasmeijer EI, van Rengen A, de Roos KP, Nijsten TEC, de Vries E, de Bekker-Grob EW.
van Egmond S, et al. Among authors: de roos kp.
PLoS One. 2022 Jan 24;17(1):e0260978. doi: 10.1371/journal.pone.0260978. eCollection 2022.
PLoS One. 2022.
PMID: 35073333
Free PMC article.